NEW YORK (GenomeWeb) – Applied BioCode announced today that it has received CE mark certification for its BioCode MDx 3000 molecular testing platform and Gastrointestinal Pathogen Panel (GPP).

The BioCode MDx-3000 is a high-volume, automated PCR-based molecular diagnostics platform designed for use by large hospitals and reference labs. The system can process up to 94 samples in about 3.5 hours, or up to 3,384 results in an 8-hour shift, the Santa Fe Springs, California-based firm said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.